CNR1 and Parkinson disease: Researchers also suggested the importance of CB1R agonists for the reduction of tremors caused by excessive stimulation of subthalamic neurons in PD patients (Sañudo-Peña et al., 1999) and to alleviate dyskinesia related to long-term levodopa treatment (Ferrer et al., 2003).